An AFE, or amniotic fluid embolism, is a rare and life-threatening emergency that occurs when amniotic fluid or fetal material enters the mother’s bloodstream during labor, delivery, or shortly after birth. It affects roughly 1 to 7 in every 100,000 deliveries, with mortality rates reported between 11% and 43%. Despite its rarity, AFE is one of the leading causes of maternal death in developed countries because it strikes suddenly and progresses within minutes.
How an AFE Happens
During pregnancy, amniotic fluid surrounds and cushions the baby inside the uterus. Normally, a barrier exists between that fluid and the mother’s blood supply. In an AFE, that barrier breaks down. Amniotic fluid along with tiny fetal particles (skin cells, hair, mucus from the baby’s gut) enters the mother’s circulation through the placental site, cervical veins, or a surgical incision from a cesarean section.
What makes this so dangerous isn’t simply the physical blockage of those particles. The mother’s immune system treats the foreign material as a threat and launches an intense inflammatory reaction, similar to a severe allergic response. This flood of inflammatory signals causes blood vessels in the lungs to clamp down, airways to constrict, and the heart to struggle under the sudden pressure. At the same time, the body’s clotting system goes haywire, activating clotting and bleeding pathways simultaneously in a condition called disseminated intravascular coagulation (DIC), which can lead to uncontrollable hemorrhage.
The Classic Signs
AFE typically presents as a sudden triad of three problems happening at once:
- Dangerously low blood pressure, often with full cardiovascular collapse or cardiac arrest
- Severe breathing difficulty, with oxygen levels dropping rapidly, bluish skin, and shortness of breath
- Uncontrolled bleeding caused by the blood’s inability to clot properly
These symptoms come on with almost no warning. A woman who appeared stable moments earlier may suddenly lose consciousness, stop breathing, or go into cardiac arrest. The speed of onset is what distinguishes AFE from most other childbirth complications. In many cases, the first recognizable sign is a sudden drop in blood pressure or an abrupt change in the fetal heart rate monitor, followed within minutes by respiratory failure and bleeding.
Two Phases of Collapse
The body’s response to AFE generally unfolds in two stages. In the first phase, the inflammatory reaction causes intense constriction of blood vessels in the lungs. This spike in pressure overwhelms the right side of the heart, which is responsible for pumping blood to the lungs. Oxygen levels plummet, and the heart can fail within minutes.
If the mother survives that initial wave, a second phase often follows. The left side of the heart begins to fail, blood pressure stays critically low, and DIC sets in. This is when massive bleeding becomes the dominant threat. Blood may pour from the uterus, from IV sites, or even from the gums, because the body has essentially used up its clotting factors. The transition from phase one to phase two can happen in as little as 15 to 30 minutes.
Who Is at Higher Risk
AFE can happen to anyone during childbirth, and there is no reliable way to predict or prevent it. That said, research has identified several factors that appear to increase the likelihood:
- Maternal age over 35, which is associated with both higher incidence and higher fatality rates
- Cesarean delivery, likely because the surgical incision creates a direct pathway for amniotic fluid to enter the bloodstream
- Placental problems such as placenta previa (placenta covering the cervix), placental abruption (placenta separating early), or placenta accreta (placenta growing too deeply into the uterine wall)
- Induced labor
- Instrumental delivery using forceps or vacuum
- Carrying multiples (twins, triplets)
- Excess amniotic fluid (polyhydramnios)
Most of these risk factors share a common thread: they involve situations where the boundary between the amniotic fluid and the mother’s blood supply is more likely to be disrupted. But many AFE cases occur in women with no identifiable risk factors at all, which is part of what makes the condition so unpredictable.
How AFE Is Diagnosed
There is no blood test or scan that can confirm an AFE in real time. It is a clinical diagnosis, meaning doctors identify it based on the pattern of symptoms and by ruling out other explanations. The sudden combination of cardiovascular collapse, respiratory failure, and uncontrollable bleeding during or just after delivery is the hallmark pattern. Other conditions that can look similar, such as a blood clot in the lungs, a severe allergic reaction, heart attack, or a ruptured uterus, need to be considered and excluded.
A large study published in JAMA Network Open found that when strict diagnostic criteria were applied (requiring cardiac arrest and coagulopathy alongside the initial collapse), the incidence dropped to about 1.7 per 100,000 deliveries. This highlights how diagnosis can vary depending on which definition is used, and why reported incidence rates range so widely across different studies and countries.
What Treatment Looks Like
Because AFE progresses so rapidly, treatment is entirely focused on keeping the mother alive through the crisis. This means aggressive support for the heart and lungs, restoring blood pressure, providing oxygen or mechanical ventilation, and replacing blood products to counteract the clotting failure. If the baby has not yet been delivered, an emergency cesarean is typically performed within minutes.
There is no cure or specific reversal agent for AFE. The goal is to support the body’s vital functions long enough for the inflammatory storm to pass. Survival depends heavily on how quickly the medical team recognizes what is happening and how rapidly they can mobilize resources. Treatment typically requires a full intensive care team, including anesthesiologists, obstetricians, and blood bank support working simultaneously.
Survival and Long-Term Recovery
Survival rates have improved over recent decades thanks to better recognition and faster access to critical care. Still, mortality remains high compared to other obstetric emergencies, with case fatality rates reported between 11% and 43% depending on the study and diagnostic criteria used.
For survivors, the recovery picture varies widely. Because the brain is extremely sensitive to oxygen deprivation, neurological injury is one of the most serious long-term concerns. Women who experienced prolonged cardiac arrest or sustained low oxygen levels may face lasting cognitive difficulties, memory problems, or other neurological deficits. Heart function can also be affected in the weeks and months following the event, though some women recover cardiac function fully over time.
The baby’s outcome depends largely on timing. If the AFE occurs before delivery, the sudden drop in the mother’s blood pressure and oxygen means the baby is also deprived of oxygen. Rapid delivery, ideally within minutes, gives the baby the best chance. Babies delivered quickly after maternal collapse generally have better outcomes than those where delivery was delayed.
For families affected by AFE, the psychological impact can be profound. A birth that was expected to be routine transforms into a life-threatening emergency in seconds. Survivors often deal with post-traumatic stress, and the experience can shape decisions about future pregnancies, though AFE recurring in a subsequent pregnancy is considered extremely rare.